Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025, and recent corporate updates.

Adaptive Biotechnologies Corp (ADPT) reports a 102% revenue increase and improved financial guidance, showcasing robust ...

Generated revenue of $35 million, driven by strong performance of the foundational PAC businessReported Adjusted EBITDA of $5.2 million, ...

Q3 2025 Earnings Call Transcript November 4, 2025 Exagen Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, ...

During the exhibition, BV will highlight its comprehensive solutions under the three key pillars of net-zero transformation — New Energy, Sustainability, and Cybersecurity — demonstrating BV's strong ...

Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsCamilla Zuckero - Vice President of Investor ...

AutoNation, Inc. (AN) 49th Annual Automotive Symposium November 4, 2025 12:00 PM ESTCompany ParticipantsJeffrey Butler - President of ...

The IONIQ 9 earned the highest possible "Good" ratings across all IIHS evaluation categories, including front and side crash protection and forward collision prevention. Sportage improved upon its ...

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...

Modernization is not optional anymore. It’s literally the question of your business survival. Usage of obsolete systems is ...

First Solar Inc (FSLR) reports robust earnings and revenue growth, while navigating booking terminations and supply chain ...